Sign in

CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company

PULSE BIOSCIENCES, INC.

Sign in to watch
Ticker
PLSE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465696597
Phone
510-906-4600
Business address
3957 POINT EDEN WAY, HAYWARD, CA, 94545
Former names
Electroblate, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Planned sale Chief Commercial Officer sold 4,600 shares at $18.53 ($85,238)
  3. 4 Planned sale Chief Commercial Officer sold 20,400 shares at an average $18.49 ($377,192)
  4. 4 Planned sale Chief Technology Officer sold 45,000 shares at an average $16.25 ($731,200)
  5. 4 Planned sale Chief Technology Officer sold 75,000 shares at an average $14.96 ($1,121,750)
  6. 4 Open-market buy Director bought 192,599 shares at an average $14.48 ($2,788,624)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Chief Technology Officer sold 30,000 shares at an average $16.19 ($485,700)
  14. 4 Option exercise Director acquired 60,242 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Former President and CEO sold 50,000 shares at $17.42 ($871,000)
  17. 4 Option exercise Director acquired 5,306,156 shares (option exercise)
  18. 4 Open-market buy Director bought 55,256 shares at $17.18 ($949,298)
  19. 4 Open-market buy Director bought 45,404 shares at $17.13 ($777,771)
  20. 4 Open-market buy Director bought 56,054 shares at an average $17.35 ($972,344)

Page 2 of 12 · 231 filings